Hypericin in the Dark: Foe or Ally in Photodynamic TherapyReportar como inadecuado


Hypericin in the Dark: Foe or Ally in Photodynamic Therapy


Hypericin in the Dark: Foe or Ally in Photodynamic Therapy - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

1

Center for Interdisciplinary Biosciences, PJ Safarik University in Kosice, Kosice 040 01, Slovakia

2

Department of Biophysics, Faculty of Natural Sciences, PJ Safarik University in Kosice, Kosice 040 01, Slovakia





*

Author to whom correspondence should be addressed.



Academic Editor: Michael R. Hamblin

Abstract Photosensitizers PSs in photodynamic therapy PDT are, in most cases, administered systemically with preferential accumulation in malignant tissues; however, exposure of non-malignant tissues to PS may also be clinically relevant, when PS molecules affect the pro-apoptotic cascade without illumination. Hypericin Hyp as PS and its derivatives have long been studied, regarding their photodynamic and photocytotoxic characteristics. Hyp and its derivatives have displayed light-activated antiproliferative and cytotoxic effects in many tumor cell lines without cytotoxicity in the dark. However, light-independent effects of Hyp have emerged. Contrary to the acclaimed Hyp minimal dark cytotoxicity and preferential accumulation in tumor cells, it was recently been shown that non-malignant and malignant cells uptake Hyp at a similar level. In addition, Hyp has displayed light-independent toxicity and anti-proliferative effects in a wide range of concentrations. There are multiple mechanisms underlying Hyp light-independent effects, and we are still missing many details about them. In this paper, we focus on Hyp light-independent effects at several sub-cellular levels—protein distribution and synthesis, organelle ultrastructure and function, and Hyp light-independent effects regarding reactive oxygen species ROS. We summarize work from our laboratories and that of others to reveal an intricate network of the Hyp light-independent effects. We propose a schematic model of pro- and anti-apoptotic protein dynamics between cell organelles due to Hyp presence without illumination. Based on our model, Hyp can be explored as an adjuvant therapeutic drug in combination with chemo- or radiation cancer therapy. View Full-Text

Keywords: hypericin; PKC; Bcl2; BAX; oxidative stress; glioma cells; endothelial cells; cancer hypericin; PKC; Bcl2; BAX; oxidative stress; glioma cells; endothelial cells; cancer





Autor: Veronika Huntosova 1 and Katarina Stroffekova 2,*

Fuente: http://mdpi.com/



DESCARGAR PDF




Documentos relacionados